Dana Tlais

Hematology | Oncology

262 Danny Thomas Pl
Memphis, TN 38105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response.

Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response.

Journal: Acta neuropathologica

Published: September 03, 2025

CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials.

CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials.

Journal: Cancer metastasis reviews

Published: April 22, 2024

Improving Time to Antibiotic Administration for Pediatric Oncology Patients With New-Onset Fever.

Improving Time to Antibiotic Administration for Pediatric Oncology Patients With New-Onset Fever.

Journal: JCO oncology practice

Published: February 14, 2024

CHEK2 mutations in pediatric brain tumors.

CHEK2 mutations in pediatric brain tumors.

Journal: Neuro-oncology advances

Published: May 19, 2023

A Toddler With New Seizures, Progressive White Matter Lesions, and Multifocal Microhemorrhages.

A Toddler With New Seizures, Progressive White Matter Lesions, and Multifocal Microhemorrhages.

Journal: Pediatrics

Published: June 24, 2022

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.

Journal: Cancer discovery

Published: July 22, 2020

Showing 1-6 of 6

Last Updated: 09/26/2026